Search results
This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant therapy.
the British Society of Gastroenterology (BSG) Endoscopy Committee with input from major stakeholders, to provide a detailed update, incorporating recent advances in sedation for gastrointestinal endoscopy. This guideline covers aspects from pre-assessment of the elective ’well’ patient to patients with significant
This is a collaboration between the British Society of Gas-troenterology (BSG) and the European Society of Gastroin-testinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplate-let or anticoagulant therapy.
1.1 General principles. Owing to the invasive nature and potential risks, we recommend that all endoscopic procedures of the GI tract require written consent, except in an emergency. Strong recommendation, mod-erate quality evidence.
The British Society of Gastroenterology (BSG) endoscopy committee agreed to create a guideline to provide statements and recommendations on the prevalence, risks, diagnosis, treatment, surveillance and screening of gastric premalignant and early gastric malignant lesions.
Management of antiplatelet therapy and direct oral anticoagulants (DOACs) in acute gastrointestinal haemorrhage is discussed in detail in European Society of Gastrointestinal Endoscopy (ESGE)
ESGE recommends device-assisted enteroscopy with small-bowel biopsy in patients with noncontributory ileocolonoscopy and with suspicion of Crohn’s disease on small-bowel cross-sectional ima-ging modalities or small-bowel capsule endoscopy.
